Author: Samirs

Precision Exosome Therapeutics

Menu

About Us
Our Science
Pipeline
Scientists
Compassionate Use
Investors
Contact

Regulatory notice: The information provided here is for informational purposes only and does not constitute medical advice or an offer or guarantee of treatment. Exousia Bio’s oncology products and therapeutic technologies described herein are investigational and have not been approved by the U.S. Food and Drug Administration for the diagnosis, treatment, cure, or prevention of cancer or any other disease. FDA Orphan Drug Designation does not constitute FDA approval and does not establish the safety or effectiveness of an investigational product. Decisions regarding Expanded Access are made on an individual basis and are subject to medical review, product availability, applicable regulatory requirements, and authorization from Exousia Bio and relevant regulatory and institutional authorities. Statements regarding future development, markets, or milestones are forward-looking and subject to risk.